Full article: Novel multi-target ligands of dopamine and serotonin

Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction

Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease - ScienceDirect

Frontiers Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation - ScienceDirect

Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse - Schenk - 2021 - Journal of Neurochemistry - Wiley Online Library

Full article: Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

Serotonin receptors contribute to dopamine depression of lateral inhibition in the nucleus accumbens - ScienceDirect

N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands

Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine

Identification and Characterization of ML321: A Novel and Highly Selective D2 Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity

Further Studies on Triazinoindoles as Potential Novel Multitarget-Directed Anti-Alzheimer's Agents

Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone